Be-Tabs Ascorbic Acid 500 mg Tablet.
PDF Leaflet Revision Date: 16 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ascorbic acid deficiency, especially scurvy.
Dosage (summary)
500 mg orally twice daily after meals, max 1000 mg/day.
Special Populations
- Renal impairment
- Hyperoxaluria
Pregnancy & Breastfeeding
Caution in pregnancy; excreted in breast milk but not hazardous.
Key Drug Interactions
- Increases renal excretion of amphetamine
- Decreases plasma ascorbate with smoking
- Increases iron absorption
- Interferes with glucose tests
Contraindications
- Hypersensitivity to ascorbic acid
- Hyperoxaluria
Common side effects
- Headache
- Flushing
- Nausea
- Vomiting
- Stomach cramps
- Diarrhoea
Counselling Points
- Take after meals
- Report any unusual symptoms
- Avoid high doses if at risk of hyperoxaluria
Serious warnings
- Tolerance may develop with high doses
- May interfere with serological tests
Important Disclaimer
The Be-Tabs Ascorbic Acid 500 mg Tablet. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
